Comparative quantification of umbilical cord blood CD34+ and CD34+ bright cells using the ProCount™-BD and ISHAGE protocols

Brazilian Journal of Medical and Biological Research

Volumn 39, Issue 7, 2006, Pages 901-906

  Pranke, P ^a,b,c   Hendrikx, J ^c   Alespeiti, G ^c   Nardi, N ^a   Rubinstein, P ^c   Visser, J ^c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c NEW YORK BLOOD CENTER   (United States)

Author keywords

Hematopoietic stem cell; Human umbilical cord blood; ISHAGE; ProCount

Indexed keywords

CD34 ANTIGEN; DACTINOMYCIN;

ANALYTIC METHOD; APOPTOSIS; ARTICLE; BLOOD SAMPLING; BONE MARROW; CD34 SELECTION; CELL COUNT; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; QUANTITATIVE ANALYSIS; UMBILICAL CORD BLOOD;

EID: 33746378368     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2006000700008     Document Type: Article

References (38)

1. Gasparoni A, Ciardelli L, Avanzini MA, Bonfichi M, di Mario M, Piazzi G, et al. Immunophenotypic changes of fetal cord blood hematopoietic progenitor cells during gestation. Pediatr Res 2000; 47: 825-829.
2. Jin CH, Takada H, Nomura A, Takahata Y, Nakayama H, Kajiwara M, et al. Immunophenotypic and functional characterization of CD33(+)CD34(+) cells in human cord blood of preterm neonates. Exp Hematol 2000; 28: 1174-1180.
3. Verfaillie CM. Anatomy and physiology of hematopoiesis. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, et al. (Editors), Hematology - basic principles and practice. 3rd edn. New York: Churchill Livingstone; 2000.
4. Williams DA. Stem cell model of hematopoiesis. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, et al. (Editors), Hematology - basic principles and practice. 3rd edn. New York: Churchill Livingstone; 2000.
5. Quesenberry PJ, Colvin GA. Hematopoietic stem cells, progenitor cells, and cytokines. In: Williams JW, Beutler E, Coller BS, Lichtman MA, Kipps TJ, Seligsohn U (Editors), Hematology. 6th edn. New York: McGraw-Hill; 2001.
6. Chivu M, Diaconu CC, Bleotu C, Alexiu I, Brasoveanu L, Cernescu C. The comparison of different protocols for expansion of umbilicalcord blood hematopoietic stem cells. J Cell Mol Med 2004; 8: 223-231.
7. Hirata Y, Sata M, Motomura N, Takanashi M, Suematsu Y, Ono M, et al. Human umbilical cord blood cells improve cardiac function after myocardial infarction. Biochem Biophys Res Commun 2005; 327: 609-614.
8. McNiece I, Kubegov D, Kerzic P, Shpall EJ, Gross S. Increased expansion and differentiation of cord blood products using a two-step expansion culture. Exp Hematol 2000; 28: 1181-1186.
9. Wada RK, Bradford A, Moogk M, Yim R, Strong DM, Drachman J, et al. Cord blood units collected at a remote site: a collaborative endeavor to collect umbilical cord blood through the Hawaii Cord Blood Bank and store the units at the Puget Sound Blood Center. Transfusion 2004; 44: 111-118.
10. McNiece I, Briddell R. Ex vivo expansion of hematopoietic progenitor cells and mature cells. Exp Hematol 2001; 29: 3-11.
11. Perotti CG, Del Fante C, Viarengo G, Papa P, Rocchi L, Bergamaschi P, et al. A new automated cell washer device for thawed cord blood units. Transfusion 2004; 44: 900-906.
12. Cohen Y, Nagler A. Umbilical cord blood transplantation - how, when and for whom? Blood Rev 2004; 18: 167-179.
13. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004; 351: 2265-2275.
14. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 1996; 5: 213-226.
15. Lögdberg L, Hendrikx J, Alespeiti G, Rafii S, Rubinstein P, Visser JWM. On the nature of CD34+ bright staining cells in human umbilical cord blood. Implications for estimating stem cells by CD34 counts. Blood 2000; 96.(Suppl 1): 381 (Abstract).
16. Greco NJ, Lee WR, Kurtz J, Seetharaman S, Moroff G. Characterization of multiple CD34+ cell populations in cord blood. J Hematother Stem Cell Res 2003; 12: 199-213.
17. Philpott NJ, Turner AJ, Scopes J, Westby M, Marsh JC, Gordon-Smith EC, et al. The use of 7-amino actinomycin D in identifying apoptosis: simplicity of use and broad spectrum of application compared with other techniques. Blood 1996; 87: 2244-2251.
18. Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R, et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997; 337: 373-381.
19. Campagnoli C, Fisk N, Overton T, Bennett P, Watts T, Roberts I. Circulating hematopoietic progenitor cells in first trimester fetal blood. Blood 2000; 95: 1967-1972.
20. Yap C, Loh MT, Heng KK, Tan P, Yu SL, Chan SH, et al. Variability in CD34+ cell counts in umbilical cord blood: implications for cord blood transplants. Gynecol Obstet Invest 2000; 50: 258-259.
21. Aroviita P, Teramo K, Hiilesmaa V, Westman P, Kekomaki R. Birthweight of full-term infants is associated with cord blood CD34+ cell concentration. Acta Paediatr 2004; 93: 1323-1329.
22. Hao QL, Shah AJ, Thiemann FT, Smogorzewska EM, Crooks GM. A functional comparison of CD34+. Blood 1995; 86: 3745-3753.
23. Shields LE, Andrews RG. Gestational age changes in circulating CD34+ hematopoietic stem/progenitor cells in fetal cord blood. Am J Obstet Gynecol 1998; 178: 931-937.
24. D'Arena G, Musto P, Cascavilla N, Di Giorgio G, Zendoli F, Carotenuto M. Human umbilical cord blood: immunophenotypic heterogeneity of CD34+ hematopoietic progenitor cells. Haematologica 1996; 81: 404-409.
25. Pranke P, Failace RR, Allebrandt WF, Steibel G, Schmidt F, Nardi NB. Hematologic and immunophenotypic characterization of human umbilical cord blood. Acta Haematol 2001; 105: 71-76.
26. Pranke P, Hendrikx J, Debnath G, Alespeiti G, Rubinstein P, Nardi N, et al. Immunophenotype of hematopoietic stem cells from placental/umbilical cord blood after culture. Braz J Med Biol Res 2005; 38: 1775-1789.
27. Chivu M, Diaconu CC, Brasoveanu L, Alexiu I, Bleotu C, Banceanu G, et al. Ex vivo differentiation of umbilical cord blood progenitor cells in the presence of placental conditioned medium. J Cell Mol Med 2002; 6: 609-620.
28. Lakshmipathy U, Verfaillie C. Stem cell plasticity. Blood Rev 2005; 19: 29-38.
29. Meister B, Totsch M, Mayr A, Widschwendter M, Huter O, Sperl W. Identification of CD34+ cord blood cells and their subpopulations in preterm and term neonates using three-color flow cytometry. Biol Neonate 1994; 66: 272-279.
30. Thilaganathan B, Nicolaides KH, Morgan G. Subpopulations of CD34-positive haemopoietic progenitors in fetal blood. Br J Haematol 1994; 87: 634-636.
31. Opie TM, Shields LE, Andrews RG. Cell-surface antigen expression in early and term gestation fetal hematopoietic progenitor cells. Stem Cells 1998; 16: 343-348.
32. Surbek DV, Steinmann C, Burk M, Hahn S, Tichelli A, Holzgreve W. Developmental changes in adhesion molecule expressions in umbilical cord blood CD34 hematopoietic progenitor and stem cells. Am J Obstet Gynecol 2000; 183: 1152-1157.
33. Li K, Yau FW, Fok TF, So KW, Li CK, Yuen PM. Haematopoietic stem and progenitor cells in human term and preterm neonatal blood. Vox Sang 2001; 80: 162-169.
34. Kilpatrick DC, Atkinson AP, Palmer JB, Murphy WG, Turner ML. Developmental variation in stem-cell markers from human fetal liver and umbilical cord blood leukocytes. Transfus Med 1998; 8: 103-109.
35. Brocklebank AM, Sparrow RL. Enumeration of CD34+ cells in cord blood: a variation on a single-platform flow cytometric method based on the ISHAGE gating strategy. Cytometry 2001; 46: 254-261.
36. Keeney M, Gratama JW, Sutherland DR, Critical role of flow cytometry in evaluating peripheral blood hematopoietic stem cell grafts. Cytometry A 2004; 58: 72-75.
37. Bayer-Zwirello LA, Hoffman DE, Adams LA, Wilder PT, Reece MT. The effect of processing and cryopreservation on nucleated umbilical cord blood cells. J Perinat Med 2004; 32: 430-433.
38. Van Haute I, Lootens N, De Smet S, De Buck C, Verdegem L, Vanheusden K, et al. Viable CD34+ stem cell content of a cord blood graft: which measurement performed before transplantation is most representative? Transfusion 2004; 44: 547-554.